The activity of the company is centered in the area of health and its objective is to identify, validate, patent and commercialize early diagnostic and/or prognostic systems, as well as therapeutic targets of hepatic diseases and other great prevalence complex pathologies. To accomplish this we use, metabolomics and bioinformatics and have established a complete and highly productive platform which supports the advance of our developments.